Elekta (OTCMKTS:EKTAY) Announces Earnings Results

Elekta (OTCMKTS:EKTAY) released its quarterly earnings results on Thursday. The company reported $0.06 earnings per share for the quarter, Zacks reports. The company had revenue of $521.00 million during the quarter. Elekta had a positive return on equity of 10.67% and a negative net margin of 3.32%.

Elekta Stock Performance

OTCMKTS EKTAY opened at $5.75 on Friday. The stock has a market capitalization of $2.12 billion, a price-to-earnings ratio of -35.96 and a beta of 1.01. Elekta has a twelve month low of $4.35 and a twelve month high of $6.93. The company has a current ratio of 0.95, a quick ratio of 0.73 and a debt-to-equity ratio of 0.56. The stock has a 50-day moving average of $6.01 and a 200 day moving average of $5.99.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.